fvcking amazing
anthropic bought mithril medicine, a biotech run by one person
the pattern behind it all:
- apr: anthropic buys a <10 person ai bio team for ~$400m
- jun: anthropic says it will run its own drug programs
- oct: openai buys orchestra bio
- oct: anthropic buys a biotech of one
what this means:
- the labs are buying how a team works, not a pipeline
- they're becoming drug developers
- once discovery gets cheap, the hard part is clinical trials and patient data
- that's where the next big startups get built
bio/acc